Rosemary supplementation

• Published in: PloS one Vol. 12; no. 5; p. e0177521
• Main Authors: Murino Rafacho, Bruna Paola, Portugal dos Santos, Priscila, Gonçalves, Andréa de Freitas, Fernandes, Ana Angélica Henrique, Okoshi, Katashi, Chiuso-Minicucci, Fernanda, Azevedo, Paula S, Mamede Zornoff, Leonardo Antonio, Minicucci, Marcos Ferreira, Wang, Xiang-Dong, Rupp de Paiva, Sergio Alberto
• Format: Journal Article
• Language: English
• Published: Public Library of Science 11-05-2017
• Subjects: Antioxidants (Nutrients); Care and treatment; Dietary supplements; Health aspects; Heart attack; Rosemary
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0177521

Myocardial infarction (MI) is one of the leading causes of morbidity and mortality worldwide. Dietary intervention on adverse cardiac remodeling after MI has significant clinical relevance. Rosemary leaves are a natural product with antioxidant/anti-inflammatory properties, but its effect on morphology and ventricular function after MI is unknown. To determine the effect of the dietary supplementation of rosemary leaves on cardiac remodeling after MI, male Wistar rats were divided into 6 groups after sham procedure or experimental induced MI: 1) Sham group fed standard chow (SR0, n = 23); 2) Sham group fed standard chow supplemented with 0.02% rosemary (R002) (SR002, n = 23); 3) Sham group fed standard chow supplemented with 0.2% rosemary (R02) (SR02, n = 22); 4) group submitted to MI and fed standard chow (IR0, n = 13); 5) group submitted to MI and fed standard chow supplemented with R002 (IR002, n = 8); and 6) group submitted to MI and fed standard chow supplemented with R02 (IR02, n = 9). After 3 months of the treatment, systolic pressure evaluation, echocardiography and euthanasia were performed. Left ventricular samples were evaluated for: fibrosis, cytokine levels, apoptosis, energy metabolism enzymes, and oxidative stress. Rosemary dietary supplementation attenuated cardiac remodeling by improving energy metabolism and decreasing oxidative stress. Rosemary supplementation of 0.02% improved diastolic function and reduced hypertrophy after MI. Regarding rosemary dose, 0.02% and 0.2% for rats are equivalent to 11 mg and 110 mg for humans, respectively. Our findings support further investigations of the rosemary use as adjuvant therapy in adverse cardiac remodeling.